Center-Authored Papers

Filters: Author is Sondel, Paul M  [Clear All Filters]
Journal Article
Miller JS, Morishima C, McNeel DG, Patel MR, Kohrt HE, Thompson JA, Sondel PM, Wakelee HA, Disis ML, Kaiser JC et al..  2018.  A First-in-Human Phase 1 Study of Subcutaneous Outpatient Recombinant Human IL-15 (rhIL-15) in Adults with Advanced Solid Tumors.. Clinical cancer research : an official journal of the American Association for Cancer Research. 24(7):1525-1535. Abstract
Erbe AK, Wang W, Reville PK, Carmichael L, Kim KM, Mendonca EA, Song Y, Hank JA, London WB, Naranjo A et al..  2017.  HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy.. FRONTIERS IN IMMUNOLOGY. 8 Abstract
Mody R, Naranjo A, Van Ryn C, Yu AL, London WB, Shulkin BL, Parisi MT, Servaes S-E-N, Diccianni MB, Sondel PM et al..  2017.  Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.. The Lancet. Oncology. Abstract